FindTrial
Sign In

To evaluate the role of CECT Chest and Bronchoscopy in identifying the aetiology of retinal vasculitis in patients who have presented to our centre with only ocular sign and symptoms and no manifestation of clinical features of systemic illness.

To evaluate the role of CECT Chest & Bronchoscopy in identifying the aetiology of retinal vasculitis

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2023/06/054275
Enrollment
78
Registered
2023-06-21
Start date
Unknown
Completion date
Unknown
Last updated
2023-06-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H350- Background retinopathy and retinalvascular changes

Interventions

None listed

Sponsors

Army Hospital Research and Referral
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patient of retinal vasculitis without any other clinically established systemic illness Patients available for minimum follow up of 6 months.

Exclusion criteria

Exclusion criteria: Patients who are already showing features of systemic illness and showing features of associated vasculitis attributable to said illness. Patients refusing to undergo CECT Chest and Bronchoscopy Patients having contraindications of CECT Chest and Bronchoscopy

Design outcomes

Primary

MeasureTime frame
Percentage of patients who had positive CECT findings Percentage of patients who were recommended for bronchoscopy after CECT chest Percentage of patients who have positive aetiological findings on CECt chestTimepoint: 6 months—

Secondary

MeasureTime frame
NilTimepoint: Nil—

Countries

India

Contacts

Public ContactDr S K Mishra

Army Hospital Research and Referral

Sanjusonu_2000@yahoo.com9811551327

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026